Canton Strategic (CNTN) financial statements

Healthcare · Biotechnology · Market cap $143M

Net income was -$36M.

The diluted share count rose 189253% over the period (dilution).

Income statement

Fiscal years, from Canton Strategic's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Research and development$847,272$2M$2M$4M$6M$3M
Selling, general and admin$671,879$1M$5M$6M$6M$17M
Operating income-$2M-$3M-$7M-$9M-$12M-$20M
Interest expense$246,534$831,277$2M$16,505$13,684$28,345
Pre-tax income————-$12M-$42M
Income tax——$0$0—-$6M
Net income-$2M-$2M-$8M-$9M-$12M-$36M
EPS (diluted)-$142.50-$131.25-$280.80-$107.02-$9.41-$1.12
Diluted shares0M0M0M0M1M32M

Balance sheet

Fiscal years, from Canton Strategic's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Cash and short-term investments$191,852$4,356$7M$11M$4M$12M
Total current assets$294,798$621,677$7M$11M$4M$17M
Total assets$294,798$621,677$7M$11M$4M$519M
Total current liabilities$3M$5M$1M$2M$2M$3M
Total liabilities$4M$5M$1M$2M$2M$121M
Shareholders' equity-$4M-$5M$6M$9M$1M$398M
Net debt-$191,852-$4,356-$7M-$11M-$4M-$12M

Cash flow

Fiscal years, from Canton Strategic's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Operating cash flow-$1M-$1M-$7M-$7M-$11M-$16M
Stock-based compensation$234,580$1M$800,696$831,862$710,313$3M
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CNTN.
Open CNTN in Investingly

From Canton Strategic's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.